MoveDMD Trial Open-Label Extension Results (October 2017) PPMD and Catabasis Pharmaceuticals hosted a webinar on October 11, 2017 to hear a community update on the results from the open-label extension of the MoveDMD trial. 8 years ago Research & Clinical Trial Webinars,Webinars You may also like Webinar: Staying Safe – Avoiding Falls and Recognizing Signs of Fat Embolism Syndrome (FES) 6 days ago Care Webinars,Webinars Webinar: Neuromuscular Care and Genetic Considerations in Becker 3 weeks ago Care Webinars,Webinars Becker muscular dystrophy,genetics,neuromuscular care Webinar: Building Protection – Vaccines and Dystrophinopathy 1 month ago Care Webinars,Webinars vaccines Webinar: Understanding BiPAP – Why It’s Needed, What Gets in the Way, and How to Increase Compliance 2 months ago Care Webinars,Webinars bipap Webinar: Capricor – Regulatory Update & Clinical Insights on Deramiocel for Duchenne Cardiomyopathy 3 months ago Research & Clinical Trial Webinars,Webinars capricor,cardiac,deramiocel Webinar: Edgewise Therapeutics – Update on Sevasemten Program in Becker and Duchenne Muscular Dystrophies 4 months ago Research & Clinical Trial Webinars,Webinars edgewise,sevasemten Webinar: Sarepta Therapeutics – Safety Update on ELEVIDYS in Non-Ambulatory Individuals Living with Duchenne 5 months ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta 1:14:53 Webinar: Dyne Therapeutics — The Clinical Impact of the FORCE™ Platform for Duchenne 5 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 123…27»Page 1 of 27